Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.
Saved in:
| Title: | Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer. |
|---|---|
| Authors: | Spratt DE; University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, Ohio., George DJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina., Shore ND; Carolina Urologic Research Center and GenesisCare USA, Myrtle Beach, South Carolina., Cookson MS; Department of Urology, The University of Oklahoma Health Sciences Center, Oklahoma City., Saltzstein DR; Urology San Antonio, San Antonio, Texas., Tutrone R; Chesapeake Urology, Towson, Maryland., Bossi A; Department of Radiation Oncology, Gustave Roussy Cancer Institute, Villejuif, France., Brown BA; Myovant Sciences Inc, Brisbane, California., Lu S; Myovant Sciences Inc, Brisbane, California., Fallick M; Myovant Sciences Inc, Brisbane, California., Hanson S; Pfizer Inc, New York, New York., Tombal BF; Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. |
| Source: | JAMA oncology [JAMA Oncol] 2024 May 01; Vol. 10 (5), pp. 594-602. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Clinical Trial, Phase III; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38451492 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Spratt+DE%22">Spratt DE</searchLink>; University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22George+DJ%22">George DJ</searchLink>; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.<br /><searchLink fieldCode="AU" term="%22Shore+ND%22">Shore ND</searchLink>; Carolina Urologic Research Center and GenesisCare USA, Myrtle Beach, South Carolina.<br /><searchLink fieldCode="AU" term="%22Cookson+MS%22">Cookson MS</searchLink>; Department of Urology, The University of Oklahoma Health Sciences Center, Oklahoma City.<br /><searchLink fieldCode="AU" term="%22Saltzstein+DR%22">Saltzstein DR</searchLink>; Urology San Antonio, San Antonio, Texas.<br /><searchLink fieldCode="AU" term="%22Tutrone+R%22">Tutrone R</searchLink>; Chesapeake Urology, Towson, Maryland.<br /><searchLink fieldCode="AU" term="%22Bossi+A%22">Bossi A</searchLink>; Department of Radiation Oncology, Gustave Roussy Cancer Institute, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Brown+BA%22">Brown BA</searchLink>; Myovant Sciences Inc, Brisbane, California.<br /><searchLink fieldCode="AU" term="%22Lu+S%22">Lu S</searchLink>; Myovant Sciences Inc, Brisbane, California.<br /><searchLink fieldCode="AU" term="%22Fallick+M%22">Fallick M</searchLink>; Myovant Sciences Inc, Brisbane, California.<br /><searchLink fieldCode="AU" term="%22Hanson+S%22">Hanson S</searchLink>; Pfizer Inc, New York, New York.<br /><searchLink fieldCode="AU" term="%22Tombal+BF%22">Tombal BF</searchLink>; Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101652861%22">JAMA oncology</searchLink> [JAMA Oncol] 2024 May 01; Vol. 10 (5), pp. 594-602. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Randomized Controlled Trial; Clinical Trial, Phase III; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101652861 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2374-2445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223742437%22">23742437 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38451492 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jamaoncol.2023.7279 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 594 Titles: – TitleFull: Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Spratt DE – PersonEntity: Name: NameFull: George DJ – PersonEntity: Name: NameFull: Shore ND – PersonEntity: Name: NameFull: Cookson MS – PersonEntity: Name: NameFull: Saltzstein DR – PersonEntity: Name: NameFull: Tutrone R – PersonEntity: Name: NameFull: Bossi A – PersonEntity: Name: NameFull: Brown BA – PersonEntity: Name: NameFull: Lu S – PersonEntity: Name: NameFull: Fallick M – PersonEntity: Name: NameFull: Hanson S – PersonEntity: Name: NameFull: Tombal BF IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2024 May 01 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2374-2445 Numbering: – Type: volume Value: 10 – Type: issue Value: 5 Titles: – TitleFull: JAMA oncology Type: main |
| ResultId | 1 |